Nursing in Practice4h
CPD: Case by case – acute and emergency dermatology presentations
Dermatology nurse specialist Julie Van Onselen explains how to recognise and manage acute dermatology conditions requiring ...
Relief for eczema flare-ups: How to manage symptoms if your skin condition worsens
When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.
Managed Healthcare Executive3d
FDA Approves Nemluvio for Atopic Dermatitis
This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...
Medpage Today on MSN3d
FDA Approves New IL-31 Drug for Eczema
A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...
Dr. Pimple Popper Knows What it’s Like to Struggle With a Chronic Skin Condition
Dr. Sanda Lee, aka, "Dr. Pimple Popper" opens up about her struggle with eczema and shares her best tips for keeping the skin condition under control.
Debunking Eczema Myths: Understanding Contagion And Prevention
The misconception of eczema being contagious likely arises from its association with other infections that can occur among ...
Singapore seeing more cases of moderate to severe eczema
KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...
FDA approves Nemluvio for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.